By: Ashley J. Wennersherron, Pennsylvania State University From: medicalxpress.com Cancerous tumors thrive on blood, extending their roots deep into the fabric of the tissue of their host. They alter the genetics of surrounding cells and evolve to avoid the protective attacks of immune cells. Now, Penn State researchers have developed a way to study the relationship between solid, difficult-to-treat tumors …
Breaking down barriers to care for metastatic breast cancer patients
From: Elaiza Torralba From: ucla.edu UCLA team recommends state-level policy changes to improve health insurance coverage, participation in clinical trials and access to palliative care Drawing on a series of studies and interviews with patients and caregivers, UCLA researchers from the UCLA Center for Health Policy Research and the UCLA Jonsson Comprehensive Cancer Center have published recommendations for California policymakers and patient …
Amazon Alexa skill offers supportive care to breast cancer patients
Source: Penn State University From: psu.edu Individuals with metastatic breast cancer could soon have access to personalized, supplemental supportive care through their smart speaker, thanks to new research at Penn State. A team of experts from the University’s College of Medicine and the College of Information Sciences and Technology has developed an Amazon Alexa skill to remotely deliver validated interventions …
First-Line Palbociclib/Letrozole Shows Real-World Survival Benefit in HR+ Metastatic Breast Cancer
By: Kristi Rosa From: onclive.com Palbociclib in combination with endocrine therapy resulted in improved survival outcomes in a real-world population of patients with hormone receptor–positive, HER2-negative, metastatic breast cancer vs letrozole alone in the first-line setting. Palbociclib (Ibrance) in combination with endocrine therapy resulted in improved survival outcomes in a real-world population of patients with hormone receptor (HR)–positive, HER2-negative, metastatic …
Savvy Cooperative: Paid Opportunity for People Aged 60+ with Metastatic Solid Tumor Cancer
SCREENER Requirements: Current diagnosis of metastatic cancer by a healthcare provider Proof of diagnosis will be required to participate Ages 60+ Fluent English speaker, but does not need to be the primary language U.S. resident Details: 120-minute focus group 15-minute survey From home Receive: $175 Link: https://gigs.savvy.coop/60-mets/?r=44951 Why Sign Up? Your experiences are so valuable and important to creating better …
STILL OPENED: Savvy Cooperative: Paid Opportunity for Locally Advanced or Metastatic Pancreatic Cancer Patients
SCREENER Eligibility Criteria: Adults who have been diagnosed with pancreatic cancer Verification of diagnosis will be required to participate Ages 18 years or older Have experienced symptoms in the past 30 days Currently living in the United States Able to read, write, and speak in English Details: 60-minute interview From a home computer Receive: $100 Link: https://gigs.savvy.coop/pancreatic-c/?r=44951 Why Sign Up? …
How to Navigate Metastatic Breast Cancer Test Results
From: healthline.com Metastatic breast cancer (MBC), also called stage 4 or advanced breast cancer, means that breast cancer has spread beyond the breast and nearby lymph nodes to other organs in the body, like the bones or brain. Not all breast cancers are the same. If you’ve already received an MBC diagnosis, your doctor will most likely perform additional tests …
Fulvestrant Deemed Effective as Later-Line Breast Cancer Treatment
Source: Conference Coverage From: cancertherapyadvisor.com Fulvestrant was found to be effective as an early and later-line treatment for women with hormone refractory metastatic breast cancer, according to the results of a retrospective study reported at the 17th St. Gallen International Breast Cancer Conference 2021. To conduct the study, researchers reviewed the medical records of women with hormone receptor-positive metastatic breast …
Savvy Cooperative: Paid Opportunity for Locally Advanced or Metastatic Pancreatic Cancer Patients
SCREENER Eligibility Criteria: Adults who have been diagnosed with pancreatic cancer Verification of diagnosis will be required to participate Ages 18 years or older Have experienced symptoms in the past 30 days Currently living in the United States Able to read, write, and speak in English Details: 60-minute interview From a home computer Receive: $100 Link: https://gigs.savvy.coop/pancreatic-c/?r=44951 Why Sign Up? …
CONTESSA Trial Yields Positive Results for Patients with HER2-Positive Breast Cancer
By: Sara Karlovitch From: targetedonc.com In an interview with Targeted Oncology, Joyce O’Shaughnessy, MD, chair of Breast Cancer Research and chair of Breast Cancer Prevention Research at Baylor-Sammons Cancer Center of Texas Oncology, discussed the CONTESSA study of tesetaxel with a reduced dose of capecitabine versus capecitabine alone in patients with HR-positive, HER2-negative breast cancer. New data suggests that a …